Showing results (41-50 of 1,152) with videos related to
Sort By:
Pageof 116
BMC Medical Research Methodology|September 16, 2008
The HCV Synthesis Project: scope, methodology, and preliminary resultsRebecca K Stern, Holly Hagan, Corina Lelutiu-Weinberger, et al.Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases|December 28, 2014
Influence of interleukin 10 polymorphisms -592 and -1082 to the HIV, HBV and HCV serostatus among intravenous drug usersEveli Kallas, Kristi Huik, Merit Pauskar, et al.European Journal of Public Health|September 24, 2025
The nitazene epidemic in Estonia: a first reportKatri Abel-Ollo, Mailis Tõnisson, Peep Rausberg, et al.Journal of Medical Virology|September 8, 2016
Prevalence and genotypes of GBV-C and its associations with HIV infection among persons who inject drugs in Eastern EuropeEne-Ly Jõgeda, Kristi Huik, Merit Pauskar, et al.American Journal of Health Promotion : AJHP|November 2, 2012
Homeless former smokers' interest in helping homeless current smokers quitKate Goldade, Hongfei Guo, Don Des Jarlais, et al.Annals of Epidemiology|June 25, 2023
Global epidemiology of abortion among female sex workers: a systematic review, meta-analysis, and meta-regressionMehrdad Khezri, Fatemeh Tavakoli, Sheree Schwartz, et al.AIDS and Behavior|April 5, 2020
HIV Treatment Knowledge in the Context of "Treatment as Prevention" (TasP)Margaret M Paschen-Wolff, Aimee N C Campbell, Susan Tross, et al.Plos One|November 30, 2018
Combination interventions for Hepatitis C and Cirrhosis reduction among people who inject drugs: An agent-based, networked population simulation experimentBilal Khan, Ian Duncan, Mohamad Saad, et al.Journal of Public Health (Oxford, England)|March 1, 2008
High-prevalence and high-estimated incidence of HIV infection among new injecting drug users in Estonia: need for large scale prevention programsAnneli Uusküla, Mart Kals, Kristiina Rajaleid, et al.Plos One|October 9, 2020
Presenting a conceptual framework for an HIV prevention and care continuum and assessing the feasibility of empirical measurement in Estonia: A case studyAnneli Uusküla, Peter Vickerman, Mait Raag, et al.Pageof 116